009: CMC Considerations For In-Human Studies with Drs. Edith Perez & Nathan Ihle
Business Of Biotech
00:00
The Patient Centricity Conversation
"The central tenant is that we do this work because we want to deliver answers for our patients," he says. "If we can help shrink tumors, if we can prolong a progression of tumors, I mean, we can improve survival." The business of biotech is brought to you in partnership with CITiva. Backslash emerging biotech at siteivalifesciences.com.
Play episode from 20:53
Transcript
